Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Myeloid Leukemia, Chronic
Interventions
BEHAVIORAL

Imatinib ending

Interruption of the treatment by Imatinib

Trial Locations (24)

13273

Institut Paoli Calmet, Marseille

29285

Hôpital Morvan, Brest

31059

University Hospital Toulouse, Purpan, Toulouse

33076

Institut Bergonié, Bordeaux

University Hospital Bordeaux, Groupe Hospitalier Pellegrin, Bordeaux

33604

Haut Lévêque Hospital, Pessac

38043

CHU de Grenoble, Grenoble

44035

University Hospital Hôtel-Dieu, Nantes

49033

University Hospital Angers, Angers

54500

University Hospital Brabois, Vandœuvre-lès-Nancy

57038

CHR de Metz-Thionville, Metz

58033

Centre Hospitalier de Nevers, Nevers

59037

Hôpital Claude Huriez, Lille

67000

University Hospital Strasbourg, Hôpital Civil, Strasbourg

69374

Hôpital Edouard Herriot, Lyon

75475

Hôpital Saint Louis, Paris

75743

Hôpital Necker-Enfants Malades, Paris

78157

Hôpital André Mignot, Le Chesnay

85025

Centre hospitalier-service de médecine interne Onco-Hématologique, La Roche-sur-Yon

86021

University Hospital Poitiers, Poitiers

94000

Hôpital Henri-Mondor, Créteil

94275

Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre

06202

University Hospital Nice, Nice

56 017

Centre Hospitalier Bretagne Atlantique, Vannes

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT00478985 - Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia | Biotech Hunter | Biotech Hunter